BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24157616)

  • 1. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
    Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A
    Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
    Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
    Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors.
    Chiang S; Staats PN; Senz J; Kommoss F; De Nictolis M; Huntsman DG; Gilks CB; Oliva E
    Am J Surg Pathol; 2015 May; 39(5):618-23. PubMed ID: 25581731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
    Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
    Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
    Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Buza N; Wong S; Hui P
    Int J Gynecol Pathol; 2018 Jul; 37(4):305-315. PubMed ID: 28700438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian sex cord-stromal tumours: an update in recent molecular advances.
    Lim D; Oliva E
    Pathology; 2018 Feb; 50(2):178-189. PubMed ID: 29275930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
    Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
    Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
    Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
    Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
    N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.
    McCluggage WG; Singh N; Kommoss S; Huntsman DG; Gilks CB
    Am J Surg Pathol; 2013 Sep; 37(9):1450-5. PubMed ID: 23774170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
    Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
    Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic changes in nonepithelial ovarian cancer.
    Van Nieuwenhuysen E; Lambrechts S; Lambrechts D; Leunen K; Amant F; Vergote I
    Expert Rev Anticancer Ther; 2013 Jul; 13(7):871-82. PubMed ID: 23875665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
    Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
    Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.